ArticlePloS one2025
Rising prevalence of parent-reported learning disabilities among U.S. children and adolescents aged 6-17 years: NSCH, 2016-2023.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Caregiver perceptions of online peer mentoring for youth with learning differences.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The prevalence of learning disabilities (LD) among children is a critical public health issue; however, recent LD prevalence estimates among children and adolescents aged 6-17 years, as reported by the National Survey of Children's Health (NSCH), remain largely unexplored. Data for this population-based cross-sectional study were obtained from NSCH to estimate the prevalence of LD diagnosis among U.S. children at both national and state levels, and to inspect the 8-year trends in these estimates from 2016 to 2023. Among 221,244 U.S. children, 20,644 had a history of LD diagnosis, with a weighted prevalence of 8.85% (95% CI = 8.59-9.10). Of these, 19,289 were currently diagnosed with LD, yielding a weighted prevalence of 8.26% (95% CI = 8.01-8.51). From 2016 to 2023, the prevalence of ever-diagnosed LD increased from 7.86% to 9.15%, while that of current-diagnosed LD rose from 7.32% to 8.66%, representing relative increases of 16.4% and 18.3%, respectively. The state with the highest prevalence (New Hampshire) had twice that of the state with the lowest prevalence (Utah). This study highlights a critical escalation in LD prevalence among U.S. children and adolescents between 2016 and 2023. Comprehensive screening and support programs must be implemented to enhance early identification and intervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.